119 related articles for article (PubMed ID: 21377565)
1. Measuring the AMFm.
Tren R; Hess K
Lancet; 2011 Mar; 377(9768):810; author reply 810-1. PubMed ID: 21377565
[No Abstract] [Full Text] [Related]
2. Malaria plan under scrutiny.
Maxmen A
Nature; 2012 Oct; 490(7418):13-4. PubMed ID: 23038440
[No Abstract] [Full Text] [Related]
3. Why the world needs another malaria initiative.
Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715
[No Abstract] [Full Text] [Related]
4. Focusing on quality patient care in the new global subsidy for malaria medicines.
Moon S; Pérez Casas C; Kindermans JM; de Smet M; von Schoen-Angerer T
PLoS Med; 2009 Jul; 6(7):e1000106. PubMed ID: 19621068
[TBL] [Abstract][Full Text] [Related]
5. Combating malaria. Malaria treatment: ACT two.
Enserink M
Science; 2007 Oct; 318(5850):560-3. PubMed ID: 17962536
[No Abstract] [Full Text] [Related]
6. Synthetic biology's first malaria drug meets market resistance.
Peplow M
Nature; 2016 Feb; 530(7591):389-90. PubMed ID: 26911755
[No Abstract] [Full Text] [Related]
7. Supporting the use of artemisinin in combination.
Hale VG
Nature; 2006 May; 441(7091):282. PubMed ID: 16710392
[No Abstract] [Full Text] [Related]
8. Qinghaosu (artemisinin): the price of success.
White NJ
Science; 2008 Apr; 320(5874):330-4. PubMed ID: 18420924
[TBL] [Abstract][Full Text] [Related]
9. For severe malaria, artesunate is the answer.
Shanks GD
Lancet; 2010 Nov; 376(9753):1621-2. PubMed ID: 21062665
[No Abstract] [Full Text] [Related]
10. Making antimalarial agents available in Africa.
Arrow KJ; Gelband H; Jamison DT
N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
[No Abstract] [Full Text] [Related]
11. Universal access to malaria medicines: innovation in financing and delivery.
Adeyi O; Atun R
Lancet; 2010 Nov; 376(9755):1869-71. PubMed ID: 20940074
[No Abstract] [Full Text] [Related]
12. Infectious diseases. Source of new hope against malaria is in short supply.
Enserink M
Science; 2005 Jan; 307(5706):33. PubMed ID: 15637249
[No Abstract] [Full Text] [Related]
13. Widespread availability of artemisinin monotherapy in the United States.
Rakita RM; Malhotra U
Emerg Infect Dis; 2011 May; 17(5):954-5. PubMed ID: 21529430
[No Abstract] [Full Text] [Related]
14. Malaria breakthrough raises spectre of drug resistance.
Towie N
Nature; 2006 Apr; 440(7086):852-3. PubMed ID: 16612346
[No Abstract] [Full Text] [Related]
15. Global fund switches to artemisinin.
Shetty P
Lancet Infect Dis; 2004 Aug; 4(8):477. PubMed ID: 15298018
[No Abstract] [Full Text] [Related]
16. Public health. Optimizing investments in malaria treatment and diagnosis.
Cohen JM; Woolsey AM; Sabot OJ; Gething PW; Tatem AJ; Moonen B
Science; 2012 Nov; 338(6107):612-4. PubMed ID: 23118172
[No Abstract] [Full Text] [Related]
17. Ethiopia faces severe malaria epidemic. WHO predicts 15 million people could be infected.
Das P
Lancet; 2003 Dec; 362(9401):2071. PubMed ID: 14700064
[No Abstract] [Full Text] [Related]
18. Developing national treatment policy for falciparum malaria in Africa: Malawi experience.
Malenga G; Wirima J; Kazembe P; Nyasulu Y; Mbvundula M; Nyirenda C; Sungani F; Campbell C; Molyneux M; Bronzan R; Dodoli W; Ali D; Kabuluzi S
Trans R Soc Trop Med Hyg; 2009 Apr; 103 Suppl 1():S15-8. PubMed ID: 19285699
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin combination therapies.
Duffy PE; Mutabingwa TK
Lancet; 2006 Jun; 367(9528):2037-9. PubMed ID: 16798368
[No Abstract] [Full Text] [Related]
20. Measuring the AMFm.
De Allegri M; Tiendrebéogo J; Louis VR; Yé M; Müller O
Lancet; 2011 Mar; 377(9768):810; author reply 810-1. PubMed ID: 21377567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
